As of 2023, China’s share of scientific publications in the world's 10% top-cited publications in Endocrinology, Diabetes, and Metabolism stood at a level below the 2024 forecast. The forecasted data from 2024 to 2028 shows a consistent upward trajectory, with an expected increase from 12.7% in 2024 to 14.01% in 2028.
Year-on-year growth from 2024 to 2028 indicates a steady increase of about 0.33 percentage points annually. The compound annual growth rate (CAGR) for this period reflects an optimistic upward trend, marking an average increase each year for five years.
Future trends to watch for:
- China's strategic investment in medical research and innovation.
- Collaborations with international research institutions.
- Potential focus on emerging technologies in medical sciences.
